biosurfit expands CDMO Services with advanced Blister Development capabilities

As part of our ongoing investment in innovation and specialized manufacturing, biosurfit is proud to announce the expansion of our contract development and manufacturing services (CDMO) to include blister development and liquid blister manufacturing, with a particular focus on solutions for diagnostic and healthcare applications.

Our R&D-driven approach enables us to support partners from the early development phase through to commercial-scale production. Whether for IVD reagent containment, sample preparation, or controlled liquid dispensing, our blister technologies are designed to meet the most stringent performance and regulatory standards.

From custom design and prototyping to precision filling, sealing, and scalability, our capabilities are tailored for biotech, pharma, and diagnostic developers looking to bring new technologies to market faster and more efficiently.

The new blister offering is part of our broader strategy to position biosurfit as a preferred CDMO partner for integrated, scalable, and compliant manufacturing solutions in the life sciences sector.

To learn more about our blister development services or to collaborate on your next project, visit our dedicated page or reach out to our team directly.